摘要
目的观察足叶苦素(PPP)抑制胰岛素样生长因子I受体(IGF-IR)后对肝癌细胞增殖和运动的影响。方法体外培养肝细胞L02和肝癌细胞(Bel-7404、Bei-7402、HepG2和Huh_7),以Westemblot分析IGF-IR表达,以磺酰罗丹明B法分析细胞活性;在PPP抑制IGF-IR后,以流式细胞术分析细胞周期,以ArmexinV-FITC法分析细胞凋亡;在z-VAD-FMK抑制caspases后,以均质发光法检测caspase-3/7活性;划痕试验分析细胞运动能力。对数据进行析因设计方差分析,采用t检验或one-wayANOVA法进行组间比较。结果肝细胞L02中几乎检测不到IGF-IR,各肝癌细胞中IGF-IR呈不同程度表达。PPP抑制肝癌细胞增殖呈时间和剂量依赖性,经1.0μmol/LPPP处理HepG2细胞24h,G1、S期和G2/M期细胞比例分别为2.1%±0.4%、11.0%±0.7%和87.1%±0.6%,且划痕不愈合Icaspase-3/7活陛显著增加(t=11.83,P〈0.01);HepG2细胞凋亡率为16.4%±0.4%,明显高于对照组的5.8%±0.2%(f=14.05,P〈0.01);z-VAD-FMK抑制casgases表达,HepG2细胞凋亡率为11.3%±0.7%,明显高于对照组的5.8%±0.2%(f=11.83,P〈0.01)。结论IGF-IR表达与肝癌细胞增殖、运动和凋亡相关,可能是肝癌分子靶向治疗的有效靶点。
Objective To investigate the therapeutic value of inhibiting the expression of insulin- like growth factor-I receptor (IGF-IR) using picropodophyllin (PPP) by studying the effects on proliferative and metastatic potentials of human hepatocellular carcinoma (HCC) using an in vitro cultured cell system. Methods IGF-IR expression in human HCC cell lines (Bel-7404, Bel-7402, HepG2, and Huh-7) and human hepatocytes (L02) was assessed'at baseline (pre-treatment) and after PPP treatment by western blotting. Changes in cell cycle were analyzed by flow cytometry and in cell viability by sulforhodamine B staining. Early apoptosis was detecte0/by annexin-V/FITC and propidium iodide double-staining assay. Caspase-3/7 / activity was suppressed by/z-VAD-FMK and analyzed by homogeneous luminescence assay. Effects on cell motility were tested by v/ound-scratch test. Between-group differences were assessed by t-test or one-way analysis of variance. Results IGF-IR was markedly up-regulated in all HCC cell lines (vs. non-hepatoma hepatocytes). HCC cells with PPP-inhibited IGF-IR showed time-dependent decreases in cell motility and After treatment with PPP for 24 hours, the proportion of HCC cells in G1 phase was 2.1% -4- 0.4%, viability. in S phase was 11.0% - 0.7%, and 'in G2/M phase was 87.1% - 0.6%, and no healing was observed in the wound-scratch assay. The PPP treatment induced cell apoptosis, as evidenced by enhanced caspase-3/7activity; the proportion of annexin-V+/PI cells was significantly higher in the HepG2 cells than in the non- hepatoma hepatocytes (16.4%± 0.4% vs. 5.8% ±0.2%, t = 14.05,P 〈 0.01). After z-VAD-FMK treatment, the apoptosis rate was significantly higher in the HepG2 cells than in the non-hepatoma hepatocytes ( 11.3% ±0.7% vs. 5.8%± 0.2%, t = 11.83, P 〈 0.01). Conclusion IGF-IR is associated with proliferation, cell motility, and apoptosis of HCC ceils, and may be a promising molecular target for HCC.
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2013年第5期376-380,共5页
Chinese Journal of Hepatology
基金
国家国际科技合作专项(2013DFA32150)}江苏省临床医学科技专项(BL2012053)
江苏省研究生科技创新项目(CXZZ110645)
南通市科技项目(HS2012039)
关键词
癌
肝细胞
细胞凋亡
受体
胰岛素样生长因子I
靶向治疗
Carcinoma, hepatocellular
Apoptosis
Receptor, insulin-like growth factor-I
Targeted therapy